Trial Profile
Long-term Effects of Inhaled Corticosteroids (ICS) Treatment on Sputum Bacterial and Viral Loads in COPD Patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Oct 2023
Price :
$35
*
At a glance
- Drugs Salmeterol/fluticasone propionate (Primary) ; Salmeterol
- Indications Chronic obstructive pulmonary disease
- Focus Pharmacodynamics; Proof of concept
- Acronyms PROBE
- 01 Oct 2017 Results published in the European Respiratory Journal
- 01 Jan 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 08 Oct 2010 New trial record